...
首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Use of contrast-enhanced Magnetic Resonance Imaging (MRI) to predict pathological response after trastuzumab (T) - based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (HER2BrCa)
【24h】

Use of contrast-enhanced Magnetic Resonance Imaging (MRI) to predict pathological response after trastuzumab (T) - based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (HER2BrCa)

机译:对比度增强的磁共振成像(MRI)用于预测曲妥珠单抗(T)的新辅助化疗(NAC)治疗HER2阳性乳腺癌(HER2BRCA)后的病理反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号